Register
Login:
Share:
Email Facebook Twitter




PXS Share Chat - RSS Feed

Provexis Share Chat (PXS)



Share Price: 0.605Bid: 0.00Ask: 0.00Change: 0.00 (0.00%)No Movement on Provexis
Spread: 0.00Spread as %: 0.00%Open: 0.605High: 0.00Low: 0.00Yesterday’s Close: 0.605


Share Discussion for Provexis (PXS)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


Premium Membership
riddler
Posts: 69,207
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.75
View Thread (2)
BB et al
24 Aug '14
all the points are valid and imho explain why the share price is where it is, even @ £11mln cap PXS is going to have to do something special in the next 12mths revenues/operating profit wise to justify AND is going to have to manage admin/wages well will only £500k cash

1: I have always said that IMHO FF is nothing more than a discretionary health-nuttrion aid NOT a health care panacea and I,ve said this since day 1, even PXS refer to products as below .....................

Fruitflow® powder for tablets, gel capsules and dietary supplements and

regional consumer healthcare brands containing Fruitflow

DSM Nutritional Products

2: the wages/renumeration are there to see

3
DSM ; the relationship, whenever you chose to date it from, has NOT led to accelerated operating profits

I am at a loss as to why people would KEEP throwing more money at PXS as some notable posters said last week, DESPITE there being limited visibility or hope of a game changing financial year
 
BoringBernie
Posts: 1,139
Observation
Opinion:No Opinion
Price:0.75
Dear Riddler
24 Aug '14
Your feud with Alfista is becoming tiresome.
Your selective picking out of facts from the RNS's is also tiresome.
Basically, you're tiresome.

Here's some facts for you

Net cash at the end of Sept after the EFF was used to add 287k was 558k
Net cash at year end was 515k

So cash burn for H2 was 43k

A further 45k was raised in April after year-end

They've also stated in the "Going Concern" section that they don't need to tap the market for any more cash this FY ( which doesn't mean they won't, but they don't have to ),

THe full-year results include a portion of the years salary and fees paid to Moon and Clarke. They also include the time when Ford was full-time on something liek three or four times what he's on now.

It's valid to argue about whether or not DSM will sell enough Fruitflow to justify the current market cap or a higher sp but you don't really want to have a sensible conversation, yoo just want to have a go at Alf

Kindly grow up and act like an adult.

BB
riddler
Posts: 69,207
Premium Chat Member
Observation
Opinion:No Opinion
Price:0.75
section 5-wages and salaries
23 Aug '14
unless my maths is wrong that money u said could be given to shareholders )£500k) Will instead be more than half spent on wages for directors alone
riddler
Posts: 69,207
Premium Chat Member
Observation
Opinion:No Opinion
Price:0.75
alfista
23 Aug '14
look at the renumeration section of the pxs results $;-)...£250k+ perks for 4 directors...
discretion aid supplement?....prove otherwise
alfista
Posts: 12,243
Off Topic
Opinion:No Opinion
Price:0.75
RE: alfista
23 Aug '14
Riddler wrote that Fruitflow had been "marketed by DSM for 7 year" -Truth or lie?
Riddler wrote "£250-300k a year for salaries" - Truth or lie.
Riddler wrote " discretionary diet aid" - truth or lie.

Produce evidence to the contrary, you can not because you made it up rather than research properly.
riddler
Posts: 69,207
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.75
2yrsa later
23 Aug '14
riddler
Posts: 64,015
Premium Chat Member
Off Topic

Opinion: No Opinion
Price: 1.51
FT3 Aug '12from ft.com

http://www.ft.com/cms/s/0/3da4be44-dafd-11e1-8074-00144feab49a.html#axzz22EqaWYpm

"Provexis has spent years and millions of shareholders’ money developing Fruitflow, a tomato-based product that aids cardiovascular health, since its Aim debut seven years ago. Then last year, just as Fruitflow was finding its way to market, the board changed the business model from a biotech business to food manufacturing, spending £8m on Science in Sport, which makes nutrition products. Since then Provexis has cut costs and cash burn along with non-core research programmes to focus on Fruitflow and SiS. It is SiS that has transformed revenues, which rose from £50,000 last year to £3.48m. Stephen Moon, chief executive, has high hopes that soon Fruitflow will also be revenue-generating and profitable. However, it seems that investors were hoping for more from Fruitflow . The shares fell almost 19 per cent yesterday to 1.52p
riddler
Posts: 69,207
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.75
alfista
23 Aug '14
all 4 points are the EXACT words from PXS ?
alfista
Posts: 12,243
Off Topic
Opinion:No Opinion
Price:0.75
pitiful
23 Aug '14
The lack of real research by Riddler is embarrassing, so many inaccuracies and distortions, and all because of a child like wish for failure.
Aint happening, rather the opposite.
riddler
Posts: 69,207
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.75
gixer
23 Aug '14
also with £250-300k just for 1yr salaries and still loss making, but only cash of £500k, as I said on results, expect more dilutive EFF draw downs in next 1-2mths
riddler
Posts: 69,207
Premium Chat Member
Off Topic
Opinion:No Opinion
Price:0.75
gixer
23 Aug '14
not scare mongering, just raising some issues to discuss in a mature fashion........I remember being laughed at for calling FF a "discretionary" diet aid....and the poor revenues despite countless variations/products seem to prove a lack of market traction after 7yrs of marketing by DSM?





Sign up for Live Prices


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.